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In Campylobacter jejuni-induced Guillain-Barre´ syndrome (GBS), molecular mimicry between C. jejuni
lipooligosaccharide (LOS) and host gangliosides leads to the production of cross-reactive antibodies directed
against the peripheral nerves of the host. Currently, the presence of surface exposed sialylated LOS in C. jejuni
is the single known bacterial pathogenesis factor associated with the development of GBS. Using a unique,
well-characterized strain collection, we demonstrate that GBS-associated C. jejuni strains bind preferentially
to sialoadhesin (Sn, Siglec-1, or CD169), a sialic acid receptor found on a subset of macrophages. In addition,
using a whole-cell enzyme-linked immunosorbent assay (ELISA), C. jejuni strains with sialylated LOS bound
exclusively to soluble Sn. Mass spectrometry revealed that binding was sialic acid-linkage specific with a
preference for (2,3)-linked sialic acid attached to the terminal galactose of the LOS chain as seen in the
gangliosides GD1a, GM1b, and GM3. This molecular interaction was also related to functional consequences
as a GBS-associated C. jejuni strain that bound Sn in a whole-cell ELISA adhered to surface-expressed Sn of
Sn-transfected CHO cells but was unable to adhere to wild-type CHO cells. Moreover, a sialic acid-negative
mutant of the same C. jejuni strain was unable to bind Sn-transfected CHO cells. This is the first report of the
preferential binding of GBS-associated C. jejuni strains to the Sn immune receptor (P  0.014). Moreover,
because this binding is dependent on sialylated LOS, the main pathogenic factor in GBS progression, the
present findings bring us closer to unraveling the mechanisms that lead to formation of cross-reactive
antibodies in GBS disease.
Campylobacter jejuni, a food-borne Gram-negative bacte-
rium, is the major cause of bacterial gastroenteritis worldwide.
In addition to enteritis, infection with C. jejuni may also lead to
a neurological complication called the Guillain-Barre´ syn-
drome (GBS). GBS is an autoimmune disease affecting the
peripheral nerves. Antibodies raised by the host during an
infection with C. jejuni possess the capacity to cross-react with
structures on human nerve tissue, resulting in neurological
complications for the host (38). Further, high titers of anti-
ganglioside antibodies are frequently found in the sera of GBS
patients (24, 41). Gangliosides are glycosphingolipids with an
extracellular sialylated oligosaccharide chain and a ceramide
tail that is embedded in the outer leaflet of the plasma mem-
brane. Although predominantly found in the nervous system,
gangliosides are present on other cell surfaces as well.
C. jejuni has lipooligosaccharide (LOS) structures on its
outer membrane. Biochemical and structural analysis of LOS
outer core oligosaccharides has identified sialylated moieties
that are structurally similar to several gangliosides (6, 9, 30).
During infection, the structural similarity between C. jejuni
LOS and human gangliosides, also known as molecular mim-
icry, facilitates the induction of anti-ganglioside antibodies and
the development of GBS (1, 29, 38, 40). The C. jejuni genes
involved in ganglioside mimicry are located within the LOS
biosynthesis locus, a gene cluster that is interchangeable be-
tween strains and is genetically highly diverse (18, 19). There-
fore, several LOS classes (A through S) have been identified
(31). LOS class, gene alterations, mutations, and mechanisms
such as phase variation in the LOS locus contribute to struc-
tural variations in the ganglioside mimics produced (19). The
presence of LOS biosynthesis locus-encoded genes responsible
for synthesis, modification, and transfer of sialic acid, found in
LOS classes A, B, and C, is crucial in the induction of anti-
ganglioside antibodies and hence GBS (20, 36). Sialylated LOS
is also involved in other aspects of C. jejuni pathogenesis. C.
jejuni strains expressing sialylated LOS invade human epithe-
lial intestinal cells significantly more frequently than strains
expressing nonsialylated LOS (28). However, the receptor for
C. jejuni attachment to human epithelial intestinal cells is un-
known.
Certain C. jejuni strains are known to bind to Siglec-7, a
member of the sialic acid binding immunoglobulin-like lectin
(Siglec) family (8). Siglecs are present on the cell surface of a
range of immune-associated cells and are involved in cell to
cell interactions and signaling. A subset of the Siglec family,
the CD33-related Siglecs, can serve as regulators of the im-
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mune system through immunoreceptor tyrosine-based inhibi-
tory motifs (ITIMs) in their cytoplasmic tail (7, 11). In addi-
tion, several recently described human Siglecs, Siglecs-14, -15,
and -16 can interact with the immunoreceptor tyrosine-based
activation motif (ITAM) adaptor, DAP12 and therefore po-
tentially mediate the activation of intracellular signaling
(5, 10).
Sialoadhesin (Sn, Siglec-1, or CD169) is a macrophage-re-
stricted Siglec that has been associated with inflammatory and
autoimmune diseases. For example, Sn levels are elevated on
activated macrophages within the inflamed organs of several
inflammatory disorders, including rheumatoid arthritis, exper-
imental autoimmune encephalomyelitis (EAE), and experi-
mental autoimmune uveoretinitis (EAU) (22, 32, 39). This
elevated expression may have functional consequences since
Sn-deficient mice show a reduced severity of EAE and EAU
(25, 39). With a poorly conserved cytoplasmic tail and the
absence of tyrosine-based signaling motifs, Sn seems to be
more involved in cell-to-cell communication and ligand bind-
ing than intracellular immunoregulation. It has been shown
that macrophages expressing Sn can bind and internalize sial-
ylated Neisseria meningitidis in an Sn- and sialic acid-dependent
manner (26). Further, HIV-1 can interact with Sn, probably via
a sialic acid residue on gp120, with binding resulting in en-
hanced infectivity and facilitates transinfections in alpha inter-
feron (IFN-)-stimulated CD14 monocytes. Furthermore, Sn
gene expression is elevated in CD14 monocytes from patients
infected with HIV-1 (34).
Each Siglec has a unique specificity for certain sialylated
glycans, with Sn preferring sialic acid conjugates with an
(2,3)galactose (gal) linkage (12). This (2,3)Gal linkage is
often found on the LOS of GBS-associated C. jejuni strains.
Because of the connection of C. jejuni infection with auto-
immune disease such as GBS and its clinical variant Miller-
Fisher syndrome (MFS), we investigated whether (2,3)-linked
sialic acid residues on the surface of C. jejuni strains could
interact with Sn and whether this interaction was characteristic
for GBS-associated strains.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains utilized in the
present study comprise (i) a group of eight Penner serotype reference strains (3,
35) (see Table S1A in the supplemental material), (ii) 29 well-characterized
GBS- or MFS-associated C. jejuni strains isolated from GBS and MFS patient
stool samples (GB13, GB14, GB26, and GB27 were cultured from the diarrheal
stools of family members of two GBS patients after a family outbreak of C. jejuni
enteritis) (4, 21, 27) (see Table S1B in the supplemental material), (iii) 54 age-
and sex-matched enteritis-associated C. jejuni strains isolated from Dutch pa-
tients with active diarrhea, and (iv) a sialic acid transferase (cstII) knockout
mutant of a GBS-associated strain (GB11cstII) (20).
C. jejuni strains were cultured from80°C stocks and maintained on Colombia
blood agar (BA) plates (Becton Dickinson BV, Alphen aan den Rijn, Nether-
lands) supplemented with 10 g of vancomycin/ml in a microaerophilic atmo-
sphere at 37°C. For culture of the GB11cstII mutant strain, chloramphenicol
(20 g/ml) was added to the growth medium. Prior to experimentation, all strains
were cultured overnight on BA plates containing vancomycin only. The LOS
outer core structures of the GBS-associated strains utilized here have previously
been reported (21). LOS was purified by hot phenol-water extraction as previ-
ously described (24). For the enteritis-only strains, we used mass spectrometry
data as reported (16) to determine whether sialic acid was present in the LOS
outer core. PCR screening to verify the LOS class was performed as previously
described (20).
Cell culture and preparation of Fc conjugates. Wild-type Chinese hamster
ovary cells (CHO-wt), CHO cells expressing Sn domain 1-17 (CHO-Sn), and
CHO cells expressing an Sn mutant with an amino acid substitution in the sialic
acid binding pocket at amino acid position 97 (arginine to alanine; CHO-
SnR97A) were generated as previously described (13). Cells were maintained in
Ham/F-12 medium (PPA Laboratories, Co¨lbe, Germany), containing penicillin-
streptomycin, 2 mM L-glutamine, and 10% fetal calf serum (FCS) and were
routinely grown in plastic 75-cm2 flasks (Greiner Bio-One, Alphen aan den Rijn,
Netherlands) at 37°C in a humidified 5% CO2–95% air incubator. With respect
to Sn-Fc production, CHO cells expressing murine Sn recombinant Fc fusion
protein domain 1-3 (Sn-Fc) or its mutant form (SnR97A-Fc) were generated as
previously described (37). The cells were cultured in 225-cm2 flasks and ex-
panded into roller bottles in glutamine-free Glasgow minimal essential medium
(Sigma-Aldrich, Zwijndrecht, Netherlands) containing 100 M L-methionine
sulfoximine (Sigma-Aldrich), glutamine synthetase (GS) supplement (Sigma-
Aldrich), penicillin-streptomycin, and 10% dialyzed FCS (Invitrogen, Leek,
Netherlands). The FCS concentration was adjusted to 2% once cells covered ca.
80% of the surface of the bottle. When 100% confluence was reached, cells were
put on X-VIVO-10 serum-free medium (Lonza, Verviers, Belgium), and medium
containing Sn-Fc or SnR97A-Fc was harvested weekly. The concentration of
Sn-Fc and SnR97A-Fc produced was determined by using an Fc-specific enzyme-
linked immunosorbent assay (ELISA).
Quantification of Fc conjugates. A 96-well Maxisorb ELISA plate (Nunc, Inc.,
Uden, Netherlands) was coated with 0.01 mg of goat anti-human IgG (Sigma-
Aldrich)/ml, followed by incubation for 2 h at room temperature. After washing,
wells were blocked with 1% bovine serum albumin (BSA) in phosphate-buffered
saline (PBS). Series of 5-fold dilutions of the Sn-Fc or SnR97A-Fc conjugates
were added to the plates, followed by incubation for 2 h at room temperature.
Fivefold dilutions of a sample containing a known concentration of Siglec-Fc
were used as a reference. After washing, wells were incubated with 1/2,000-
diluted peroxidase-conjugated goat anti-human IgG (Sigma-Aldrich). Plates
were washed four times with 0.05% Tween 20 in PBS and developed with 100 l
of TMB substrate (3,3,5,5-tetramethylbenzidine; Sigma-Aldrich)/well. After
an appropriate incubation time (5 to 10 min), the reaction was stopped by adding
100 l of 2 M H2SO4/well. The intensity of the signal was measured spectropho-
tometrically at 450 nm by using a 96-well microplate reader (Bio-Rad,
Veenendaal, Netherlands), and the concentrations were determined.
Sialoadhesin-Fc ELISA. With respect to the ganglioside/SnFc ELISA, equal
amounts (300 ng/well) of purified bovine brain ganglioside (GA1, GM1, GM2,
GM3, GD1a, GD1b, GD3, and GT1b [Sigma-Aldrich]) diluted in ethanol were
applied to 96-well Maxisorp ELISA plates (Nunc, Inc.). The plates were then
incubated for 2 h at room temperature, allowing the ethanol to evaporate. For
the LOS/Sn-Fc ELISA, plates were coated overnight at 37°C using 2 g of LOS
in PBS plus 0.2% trichloroacetic acid per well. After a washing step, the wells
were blocked for 2 h at room temperature and for 2 h at 4°C with 1% BSA in PBS
(pH 7.8). In the meantime, 1.25 g of Sn-Fc conjugate/ml was precomplexed with
1/4,000-diluted peroxidase-conjugated anti-human IgG (IgG-PO) (Sigma-Al-
drich) in PBS with 0.05% normal goat serum for 1 h at room temperature with
shaking. After a washing step, 100 l of precomplexed Sn-Fc was added/well, and
the plates were incubated for 2 h at room temperature. Plates were washed four
times with PBS and developed using TMB as previously mentioned.
Finally, for the C. jejuni–Sn-Fc ELISA, fresh overnight C. jejuni cultures grown
on BA plates were harvested and washed, and the optical density at 600 nm
(OD600) was adjusted to 0.2 in /PBS (i.e., PBS containing 2 mM CaCl2 and
2 mM MgCl2). After heat inactivation at 56°C for 45 min, 100 l of each
sample/well was added in duplicate to 96-well Maxisorp ELISA plates (Nunc,
Inc.), and the open plates were incubated overnight at 37°C in order to allow the
fluid to evaporate. After overnight incubation and washing, wells were blocked
for 1 h with 1% BSA in PBS at 37°C. In some cases, the bacteria were pretreated
with neuraminidase for 16 h using 0.05 U of Arthrobacter ureafaciens 2-3,6,8,9-
neuraminidase (Calbiochem, Breda, Netherlands)/ml in PBS–1% BSA. There-
after, the ELISA protocol previously described for the ganglioside Sn-Fc ELISA
was followed with the exception that the C. jejuni/Sn-Fc ELISA plates were
washed with PBS containing 0.05% Tween 20 to minimize nonspecific binding.
Statistical procedure. For statistical analysis, the strains were divided into
either positive or negative groups depending on their Sn binding properties.
Strains exhibiting an OD450 value higher than 2 times the background signal plus
2 times the standard deviation were classified as positive for Sn binding and
strains with a lower OD450 signal as a negative. The chi-square test was used to
indicate whether a significant difference existed in Sn binding between GBS-
associated and enteritis-only strains. We consider P  0.05 to be statistically
significant.
FITC labeling of C. jejuni. Fresh overnight cultured C. jejuni was harvested
in /PBS and incubated for 1 h with 5 l of fluorescein isothiocyanate (FITC;
100 mg/ml in dimethyl sulfoxide)/ml with shaking. Bacteria were washed in PBS
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and heat inactivated for 45 min at 56°C, and the OD600 was adjusted to 1.0 in
/PBS.
Binding of C. jejuni to Sn-expressing and wild-type CHO cells. CHO-wt,
CHO-Sn, and CHO-SnR97A cells were grown to 80% confluence on glass
coverslips and, after being washed with serum-free medium, were incubated for
2 h at 37°C along with various FITC-labeled C. jejuni strains in media containing
1% FCS. For this procedure, a bacterium/cell ratio of 100:1 was used. After a
washing step, the cells were fixed for 20 min in methanol at 20°C and coun-
terstained using 3 M propidium iodide (PI). For flow cytometry analysis, semi-
confluent CHO cells were harvested from 75-cm2 flasks using PBS containing 2
mM EDTA. Cells were incubated for 45 min with FITC-labeled bacteria (bac-
terium/cell ratio of 100:1) in a 37°C incubator with shaking. After being washed,
the cells were analyzed by using a FACSCalibur (Becton Dickinson BV). In
control experiments, the cells were incubated for 15 min with 1/10-diluted 3D6,
a monoclonal rat anti-mouse antibody raised against Sn, prior to incubation with
the bacteria. To confirm Sn expression on CHO-Sn and CHO-SnR97A, 1/100-
diluted 3D6 and 1/1,000-diluted Alexa Fluor 633-conjugated goat anti-rat
IgG(HL) secondary antibody (Invitrogen) was used.
RESULTS
Binding of Sn-Fc to purified gangliosides. To validate our
batch of Sn-Fc and to extend our knowledge of Sn/ganglioside
interactions and affinities using ELISA, we determined the
ability of Sn-Fc to bind to a panel of purified bovine brain
gangliosides. Gangliosides were coated on ELISA plates and
incubated with Sn-Fc precomplexed with anti-human IgG-PO.
It has been shown that Sn preferentially binds to (2,3)-linked
sialic acid glycoconjugates with strong affinity for sialic acid
residues in the terminal position of a Gal-GalNac-Gal back-
bone (12). We confirmed these findings with Sn binding prop-
erties in a ranking order of GD1a  GT1b  GM3. No Sn
binding was observed either when sialic acid was absent (GA1),
sialic acid was linked to the inner galactose of (Gal)-GalNac-
Gal (GM1a and GM2), or there was an (2,8)-linkage (GD1b
and GD3) (Fig. 1 and 2). In conclusion, the binding efficiency
of the Sn variant used here is in agreement with literature data.
Sialic acid-dependent interaction of Sn-Fc with heat-inacti-
vated C. jejuni strains and purified LOS. Similar to the gan-
glioside ELISA described above, we set up a whole-cell bac-
terial ELISA using eight heat-inactivated C. jejuni Penner
strains with known ganglioside structures. These included not
FIG. 1. Sialoadhesin-Fc binding to purified gangliosides. Purified
bovine gangliosides dissolved in ethanol were coated on ELISA plates,
incubated with Sn-Fc precomplexed with anti-human IgG-PO, and
visualized by using TMB. As a control for nonspecific binding of the
precomplexed Sn-Fc, ethanol-coated wells were used (). The data
are depicted as means and standard deviations of quadruple measure-
ments. Schematic structures of the gangliosides that were tested are
depicted in Fig. 2.
FIG. 2. Schematic representation of the human ganglioside structures relevant to the present study. The galactose-sialic acid linkages are
indicated. These structures are mimicked by C. jejuni in the outer core LOS. However, instead of the ceramide-bound glucose, the C. jejuni LOS
has a heptose, followed by an inner sugar core, and C. jejuni LOS has a lipid A transmembrane tail instead of a ceramide tail. *, GA1, GA2, and
GA3 or asialo-GM1, -GM2, and -GM3 are considered not to be gangliosides.
VOL. 78, 2010 INTERACTION BETWEEN SIALOADHESIN AND C. JEJUNI LOS 3239
 o
n
 D
ecem
ber 12, 2011 by VRIJE UNIVERSITEIT
http://iai.asm
.org/
D
ow
nloaded from
 
only Penner strains harboring ganglioside mimics that are the
most important in GBS pathology (GM1, GM2, GM3, GD1a,
and GD3) but also control strains possessing no ganglioside
mimic (none or GA3). Consistent with the ganglioside binding
pattern, we found strong Sn binding for strains P2 (GM3), P4
(GM1, GD1a), and P19 (GM1a, GD1a), all having terminal
(2,3)-linked sialic acid residues in the LOS. Sn binding was
also observed for P36 (GM2 and GM3). Surprisingly, P1
(GM2) and P10 (GD3) also showed binding to Sn. It is possible
that the presence of some undetected GM3 is responsible for
this phenomenon. Binding of Sn to strains P3 (none) and P23
(GA3), which lack ganglioside mimics, was found to be low or
zero (Fig. 3A). To confirm that these interactions were sialic
acid dependent, we treated the Penner strains with neuramin-
idase before incubation with the Sn-Fc conjugate. Neuramin-
idase treatment completely abolished Sn recognition of P2
(GM3), P4 (GM1, GD1a), P10 (GD3), and P19 (GM1, GD1a),
showing that Sn binding to these strains is sialic acid specific.
Sn binding to P1 (GM2) and P36 (GM2, GM3) was reduced,
although not to background levels. Reduction in binding is
probably due to the loss of the GM3 mimic. GM2, with an
internal sialic acid, is less sensitive to neuraminidase treatment,
so residual binding might be because of the presence of this
structure.
The ELISA was also performed with the Sn mutant
SnR97A-Fc. This mutant has an amino acid substitution
FIG. 3. Heat-inactivated C. jejuni Penner strains (A) or purified LOS of the same Penner strains (B) were coated on ELISA plates, incubated
with precomplexed Sn conjugates Sn-Fc or SnR97A-Fc, and visualized by using TMB. For binding assays, Penner strains and LOS were either left
untreated or were treated with neuraminidase. The bars represent a single experiment which was repeated at least three times, with means and
standard deviations of three measurements. Schematic structures of the ganglioside mimics that are expressed by the Penner strains are depicted
in Fig. 2.
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(R97A) in the sialic acid binding pocket and lacks the ability to
bind sialic acid conjugates. None of the strains showed binding
to SnR97A, ruling out nonspecific binding to other parts of the
protein (Fig. 3A).
To date, no ganglioside-like or sialylated structures other
than the sialylated LOS have been found on the surface of C.
jejuni strains. Therefore, Sn binding to C. jejuni strains as
observed in the whole-cell Sn-Fc ELISA is almost certainly due
to the presence of sialylated LOS structures on the bacterial
surface. To show that LOS is the ligand for Sn, we also per-
formed Sn-Fc and SnR97A-Fc ELISAs on purified LOS (Fig.
3B), using LOS from the same Penner strains as used in Fig.
3A. Other than some relative differences in signal intensity for
P19 and P36, the Sn binding pattern for purified LOS was very
similar to the Sn binding pattern for intact bacteria, indicating
that the interaction is really LOS specific.
Binding of C. jejuni to Sn-expressing CHO cells. When at-
tached to ELISA plate wells, C. jejuni and purified LOS from
C. jejuni were both able to bind to precomplexed soluble Sn. In
vivo, however, Sn is exposed on cell surfaces. Therefore, to test
whether sialic acid-dependent binding to soluble Sn could be
reproduced using cell surface-expressed Sn, we used CHO cells
stably transfected with mouse Sn cDNA (CHO-Sn). Binding of
C. jejuni to CHO-Sn cells was compared to that of parental
CHO cells (CHO-wt), as well as CHO cells transfected with
the Sn mutant R97A (CHO-SnR97A). GB11, a GBS-associ-
ated strain, and its Campylobacter sialic acid transferase knock-
out mutant (GB11cstII) were used. These strains were first
tested for Sn binding using the Sn-Fc ELISA and, as expected,
GB11 (possessing a mix of GM1a- and GD1a-like structures)
bound to Sn, whereas GB11cstII (possessing GA1, GA2, and
GA3) did not (Fig. 2 and 4A).
Immunofluorescent staining (Fig. 4B) showed a clear asso-
ciation between GB11 and Sn-expressing CHO cells but
no binding of GB11 to CHO-wt or CHO-SnR97A cells.
GB11cstII did not bind to any of the CHO cell-lines, indicat-
ing that the binding of GB11 to CHO-Sn was actually sialic
acid dependent. Flow cytometric analysis of CHO cells incu-
bated with FITC-labeled C. jejuni (Fig. 4C) confirmed these
findings with a shift in the fluorescent signal observed when
GB11 incubated with CHO-Sn was compared to GB11cstII
incubated with CHO-Sn. This effect was not observed when
GB11 and GB11cstII were incubated with CHO-wt or CHO-
SnR97A. Further, upon preincubated of CHO-Sn with 3D6, no
difference in binding was observed between GB11 and
GB11cstII, indicating that the binding was strictly Sn depen-
dent. Together, these results show that C. jejuni with ganglio-
side mimics in their LOS bind to cell-exposed Sn in a sialic
acid-dependent manner.
Sn binding properties of GBS-associated and enteritis-only
C. jejuni strains. Based on the findings that C. jejuni was able
to bind Sn in a sialic acid linkage-specific manner, with a
preference for terminal (2,3)-linked sialic acid residues, and
the knowledge that this sialic acid linkage is frequently found
in the LOS of GBS associated strains, we screened a well-
characterized GBS-associated strain collection (n 	 29), and
an age- and sex-matched enteritis control group (n 	 54) for
Sn binding. For this process, a whole-cell Sn-ELISA was used
with heat-inactivated C. jejuni strains coated onto the ELISA
plate. A total of 20 (69%) of the 29 GBS-associated strains
tested were found to be positive for Sn binding in the ELISA
(Fig. 5A), including all strains containing GD1a-like LOS
(GB2, GB3, GB11, GB18, GB21, GB22, GB28, and GB31).
The latter strains always expressed a combination of a GD1a
and a GM1a ganglioside mimic. Strains GB13 and GB14, ex-
pressing a GM1a-like structure only, produced negative Sn
binding results in the ELISA. Therefore, and because the bo-
vine ganglioside GM1a did not show binding in the ganglioside
ELISA, the GD1a part of the GD1a/GM1a harboring strains is
most likely responsible for Sn binding. Other strains that were
positive for Sn binding at least had GM1b- or GM2-like LOS
present. Strains MF7 and GB23, also with GM2-like LOS,
showed little binding. The difference in binding affinity that
was observed for strains with similar LOS structures was prob-
ably due to differences in expression rates of the mimics.
Strain GB27 showed very strong Sn binding which is surpris-
ing since we previously reported that its LOS outer core is a
GA1-like structure (21). GB27 LOS genes are identical to LOS
genes of GB26 but earlier sequence analysis had shown that
the sialyltransferase gene (cstII) was variable in these two
strains due to phase variation (i.e., alterations in a hypervari-
able homopolymeric G tract). GB26 had a 9-G tract in cstII
that predicted a complete translation product consistent with a
sialylated outer core, while GB27 had a 10-G tract that pre-
dicted a premature translation stop resulting in no sialyltrans-
ferase activity in that strain. Because of the heterogeneity of
homopolymeric G tracts, we suggest that the cstII gene had a
9-G tract and was turned on in the GB27 sample that was
tested for Sn binding. We sequenced the cstII gene of four
samples of minimally passaged GB27 cultures and indeed
found that they contained 9-G tracts (turned on) in the cstII
gene. We also confirmed the presence of a GM1b mimic in the
LOS outer core of these samples by electrophoresis-assisted
open-tubular liquid chromatography mass spectrometry (see
Table S2 in the supplemental material). Clearly, GB27 is a
strain that has the capacity to synthesize a GM1b mimic and to
bind strongly to Sn.
The GBS-associated strains were significantly more often
positive for Sn binding compared to the enteritis strains (P 	
0.014) (Table 1). For the enteritis strains, 22 (41%) of 54
strains tested were positive (Fig. 5B). All strains that were
positive for Sn binding possessed either a class A, a class B, or
a class C LOS gene locus. Strains with such an LOS class
contain genes involved in sialic acid synthesis, modification and
transfer. The LOS outer core of these enteritis-only strains
(except for strain 66) have previously been analyzed by elec-
trophoresis-assisted open-tubular liquid chromatography–elec-
trospray mass spectrometry (16). This analysis confirmed that
sialic acid was present in the LOS outer core of the enteritis-
only strains that were positive for Sn binding. The mass spec-
trometry analysis of the enteritis-only strains did not allow
determination of the complete LOS outer core structures.
However, correlations can be made for the strains that had
mass species identical to GBS and MFS strains for which the
LOS outer core structures are known (see reference 21). For
example, strains 19, 49, 71, 109, and 110 all had the same mass
species as GB13 and GB14, which were previously shown to
display GM1a mimicry. Therefore, it is reasonable to expect
that these strains also possess sialic acid in their LOS outer
cores but are still negative for Sn binding. Strains 9, 12, 13, 31,
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FIG. 4. (A) Sn binding to GBS-associated strain GB11 and the sialic acid-negative mutant GB11cstII. Whole bacteria and purified LOS were
tested for Sn binding using ELISA. A schematic representation of the ganglioside mimicking structures expressed by GB11 and GB11cstII can
be found in Fig. 2. The structures were determined by mass spectrometry and previously published (20). (B) Immunostaining of wild-type-, Sn-,
and SnR97A-expressing CHO cells, incubated with FITC-labeled GB11 or the sialic acid-negative mutant GB11cstII. Cells were counterstained
using PI. (C) Flow cytometric analysis of binding between CHO cells and C. jejuni strains. Wild-type- and Sn-expressing CHO cells were incubated
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and 41 had mass species identical to GB11, which has GM1a/
GD1a mimicry. Similar to GB11, these five strains were posi-
tive for Sn binding.
DISCUSSION
It has been well established that LOS structures, expressed
on the surface of C. jejuni, play an important role in develop-
ment of the postinfectious autoimmune disorders GBS and
MFS. Cross-reactive, nerve-damaging antibodies are produced
during infection due to molecular mimicry between C. jejuni
outer core LOS and gangliosides on peripheral nerves. The
expression of genes involved in LOS sialylation are a prereq-
uisite for mimicry, since truncated LOS structures without
sialic acid show a reduced reactivity with GBS patient serum
and fail to induce an anti-ganglioside antibody response in
mice (20).
We report here that the sialylated structures on the surface
of C. jejuni are able to specifically bind to Sn, an immune
receptor of the Siglec family that has been linked to various
autoimmune diseases. We show that the ligand for Sn is the
outer core LOS. Moreover, binding to Sn is sialic acid depen-
dent as neuraminidase-treated strains, as well as a sialic acid
transferase knockout strain, failed to bind to Sn. Sn specifically
recognizes LOS structures with a terminal (2,3)-linked sialic
acid conjugate as seen in GD1a, GM3, and GM1b. Crucially,
upon screening a large panel of pathogenic GBS-associated
and nonpathogenic enteritis strains, significantly more GBS-
associated strains bound Sn compared to enteritis-only strains
(P 	 0.014).
What is the consequence of Sn binding? It is unclear
whether binding to Sn on host cells affects the fate of C. jejuni.
Sn is expressed on a subset of macrophages, predominantly on
macrophages in the subcapsular sinus (SCS) and medulla of
the lymph nodes and on metallophilic macrophages of the
spleen (14). Lymph node macrophages are involved in captur-
ing and processing of trafficking antigens from the lymph. A
recent study (33) showed that SCS lymph node macrophages
have limited phagocytic activity; therefore, Sn binding may not
be pivotal for intracellular infection by and survival of the
bacterium. In contrast, SCS macrophages possess the ability to
retain antigens on their cellular surface, which may lead to
antigen presentation to follicular dendritic cells (FDC) (23).
As such, Sn expression on SCS macrophages may allow capture
of soluble ganglioside-mimicking LOS fragments and FDC
presentation, leading to B-cell maturation and subsequent an-
tibody production.
Another feature suggesting that Sn is not primarily involved
in the initial events of C. jejuni invasion comes from our own
observations. Although we have shown that C. jejuni strains
with sialylated LOS invade intestinal epithelial cells better than
nonsialylated strains (28), this effect was found not to be sialic
acid linkage dependent. Moreover, intestinal epithelial cells
are not known to express Sn. Therefore, factors and/or pattern
recognition receptors other than Sn must play a role in C. jejuni
invasion of the intestinal epithelium.
In the present study we used murine Sn, which has a high
degree of protein sequence similarity, up to 79% in the sialic
acid binding domain, to human Sn as well as similar (2,3)-
linkage and sialic acid-dependent binding properties (22). Ex-
trapolation to the human situation is therefore plausible.
Our results show that especially strains with a GD1a, GM3,
or GM1b ganglioside epitope and only strains with a class A, B,
or C LOS were positive for binding to Sn. Only these LOS
classes harbor genes involved in LOS sialylation and ganglio-
side mimicry. Not just GBS-associated strains but also 40.7%
of enteritis-only strains were positive for Sn binding. Although
these strains possess the Sn binding epitope, infection was not
associated with the development of neurological dysfunctions.
Therefore, other factors that play a role in macrophage-medi-
ated Sn binding and subsequent processes must contribute to
the development of GBS. Single nucleotide polymorphisms
(SNPs) that contribute to genetic variations between hosts
might alter macrophage function and behavior. Genetic poly-
morphisms in genes encoding the macrophage-mediators tu-
mor necrosis factor alpha and matrix metalloproteinase-9 have
been associated with the more severe forms of GBS (17).
Furthermore, coinfection with another bacterial species or vi-
rus might direct the immune system toward Sn-mediated au-
toimmunity. For example, viral infections can induce release of
interferons (IFNs), factors that have been shown to upregulate
Sn on the surface of monocyte-derived macrophages (15).
Not all GBS-associated strains tested were positive for Sn
binding. Strains GB13 (GM1a) and GB14 (GM1a) lack a ter-
minal (2,3)-linked sialic acid residue that, most likely, is nec-
essary for Sn binding. In fact, these strains were not isolated
from a GBS patient but from two family members of a GBS
patient during a family related C. jejuni enteritis outbreak.
Although we classified these strains as GBS-associated because
the patient serum reacted with LOS fractions from the C. jejuni
strains isolated from the family members, a separate uncul-
tured strain might have triggered the development of GBS.
Strain GB1 and GB5 with LOS classes C and B harbor genes
required for ganglioside mimicry but do not express gangli-
osidelike epitopes. Sequence analysis of these strains revealed
one or more base deletions in LOS-associated genes, resulting
in a truncated LOS outer core without sialic acid (21). Anti-
GM1 antibodies were detected in the acute-phase serum of the
GBS patient from whom strain GB1 was isolated (2). It might
be that the base deletions in the LOS of GB1 occurred later in
the course of the infection or during laboratory procedures.
Strains GB4, GB15, and GB24 lack the genes essential for
with FITC-labeled GB11 or GB11cstII, with or without preincubation using 3D6 (a monoclonal rat anti-mouse antibody against Sn). Expression
of Sn on the CHO cells was confirmed using 3D6 and an Alexa Fluor 633-labeled secondary antibody. (a to c) CHO-wt (a), CHO-Sn (b), and
CHO-SnR97A (c), incubated with GB11 and GB11cstII. (d and e) CHO-wt (d) and CHO-Sn cells (e), preincubated with 3D6 before the addition
of GB11 or GB11cstII. GB11 is depicted as filled gray curves; GB11cstII is depicted as dark gray open curves. Light gray open curves indicate
CHO cells without the addition of bacteria. (f) Expression of Sn (or Sn-R97A) on CHO cells. The light gray line is CHO-wt, the black line is
CHO-Sn, and the dark gray line is CHO-SnR97A.
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ganglioside mimicry. Although these strains were cultured
from the stools of GBS patients, no anti-ganglioside antibodies
were detected in the acute-phase sera of these patients (2, 21),
suggesting that another pathogenic mechanism than molecular
mimicry was involved.
Binding of C. jejuni strains to Siglec-7, which has a prefer-
ence for (2,8)-linked sialic acid glycans, has already been
demonstrated in an earlier study (8). In the same study, how-
ever, no binding was found for Sn, not even using LOS purified
from strain HS:19 (GM1, GD1a). Although variation in the
FIG. 5. (A) Sialoadhesin binding to GBS-associated strains. (B) Sialoadhesin binding to enteritis-only strains. Binding of Sn-Fc to GBS-
associated strains and enteritis-only strains was evaluated by ELISA. Heat-inactivated bacteria were coated onto plates, incubated with Sn-Fc
precomplexed with IgG-PO, and visualized using TMB. The bars represent a single experiment that was repeated at least two times, with the means
and standard deviations of two measurements per experiment. -, PBS control for background staining. The black line represents 2
 (signal plus
the standard deviation) the negative control. Strains with OD450 values above this line were considered to be positive for Sn binding. UT,
untypeable; NT, not tested. Schematic structures of the gangliosides mimics that are expressed by the GBS- and MFS-associated strains are
depicted in Fig. 2.
3244 HEIKEMA ET AL. INFECT. IMMUN.
 o
n
 D
ecem
ber 12, 2011 by VRIJE UNIVERSITEIT
http://iai.asm
.org/
D
ow
nloaded from
 
signals between strains was observed in our experiments, all
strains possessing GD1a-like LOS we tested were positive for
Sn binding. It is unclear, therefore, why no Sn binding was
observed with strain HS:19 in this publication (8). We also
tested our strains for binding to Siglec-7, and preliminary ex-
periments revealed that especially the MFS-associated strains
MF6, MF7, MF8, and MF20 had high affinity for Siglec-7 (data
not shown). Although these strains were also positive for Sn
binding, the Siglec-7 pathway might generate additional im-
mune responses leading to the specific oculomotor nerve dys-
function seen in MFS. Future studies will focus on this inter-
esting aspect.
In this publication, using various test systems, we demon-
strate that C. jejuni strains expressing (2,3)-linked sialylated
surface structures are able to bind to Sn. Our finding that
GBS-associated strains preferentially bind Sn compared to en-
teritis strains brings us nearer to an understanding of the
mechanisms involved in the formation of cross-reactive anti-
bodies in C. jejuni-mediated GBS.
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